Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies

This publication has 44 references indexed in Scilit:

• Electron beam fragmentation of bacterial polysaccharides as a method of producing oligosaccharides for the preparation of conjugate vaccines
  FEMS Microbiology Letters, 1999
• A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide?protein conjugate vaccines
  Vaccine, 1999
• Pneumococcal serotypes and their clinical relevance
  Thorax, 1998
• Prospects for the use of new vaccines in developing countries: cost is not the only impediment
  Vaccine, 1996
• Pneumococcal polysaccharide vaccines: Indications, efficacy and recommendations
  European Journal of Clinical Microbiology & Infectious Diseases, 1991
• Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide.
  The Journal of Experimental Medicine, 1989
• Specific antibodies to diphtheria toxin and type 6a pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen
  Molecular Immunology, 1985
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
  Proceedings of the National Academy of Sciences, 1979
• Oligosaccharide-protein conjugate: A novel approach for makingSalmonellaO-antigen immunogens
  FEMS Microbiology Letters, 1977
• CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
  The Journal of Experimental Medicine, 1931